The result indicated an obvious decrease of myogenin in PAD model (0.22 ± 0.08 vs. control group, p < .05) while administration of TMZ significantly increased myogenin expression in the ischaemic hindlimb of diabetic mice. This evidence concerns the gene MYOG and peripheral arterial disease.